Trelagliptin Sucinate CAS 1029877-94-8

Pwodwi Deskripsyon:

Non pwodwi: Trelagliptin sucinate CAS NON: 1029877-94-8

 

Sinonim:

Serr-472;

(R) -2-(6-(3-aminopiidin-1-yl) -3-methyl-2,4-dioxo-3,4-dihydromidridin-1 (2H) -yl) methyl)-4-fluorobenzonitricate sucincateur;

 

Chimik & Pwopriyete fizik:

Aparans : Blan pou poud blan

Assay: ≥99.0%

 

Trelagliptin Sucinate, devlope pa Pranda, Japon, te make an Mas 2015 anba non komes Zafatek la, itilize pou tretman kalite dyabet 2. Troxagliptin se yon ultra-long-aji validite diptid IV (DPP-4) inibitor pa selektivman ak kontinyelman entedi DPP-4 pou kontwole nivo sik san. Traxagliptin se premye oral nan mond lan yon fwa-yon semen dwog ipoglycemic, ak menm jan DPP-4 inibite sou mache a bezwen yo dwe pran oralman yon fwa nan yon jounen. Avantaj Zafatek la pral san doute bay yon opsyon tretman pi bon pou pasyan dyabetik. , Li espere amelyore konvenyans nan ak konfomite nan pasyan yo.

 

Si ou enterese nan pwodwi nou yo oswa ou gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!

 

 

Pwodwi anba patant yo ofri pou R & D rezon selman. Sepandan, denye responsablite a bay manti selman ak achte a.

 

 

 

Baj popilè: trelagliptin sucinate cas 1029877-94-8, manifaktire, founise, faktori, achte, nan stock

• On: Ipragliflozin CAS 761423-87-4
• Pwochen: Beta-Pseudouridin CAS 1445-07-4